YoY increases\/decreases in revenue and various profit metrics for the cumulative 2Q. Revenue and backlog growth are particularly notable, signaling future growth. Contributions from corporate entities and DX-related areas are expected to continue.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5619","jir_company_name":"MRSO Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/5619-20260814-02.pdf","jir_short_summary":"YoY increases\/decreases in revenue and various profit metrics for the cumulative 2Q. Revenue and backlog growth are particularly notable, signaling future growth. Contributions from corporate entities and DX-related areas are expected to continue.","jir_summary":"### Overview of the results\nFor the current period, cumulative 2Q revenue and backlog have exceeded the previous period's results, with particularly strong growth in corporate backlog. In terms of cost structure, reductions in personnel costs and parts of selling, general and administrative expenses are progressing, and movements in operating income and net income versus the same period last year are variable. Signs of business expansion are seen centered on the DX in ADX areas.\n\n### Outlook and key initiatives\nFrom the new fiscal year onwards, revenue growth is expected driven by continued expansion of corporate backlog. By optimizing the allocation of advertising, promotions, and development costs, MRSO aims to expand in the health management DX domain. It is anticipated that measures to improve profitability for the full year will continue.","jir_financial_highlights":"Revenue: Unknown (Unknown)\nOperating income: Unknown (YoY \u25b3 Unknown)\nNet income: Unknown (YoY \u25b3 Unknown)","jir_category":"","jir_hashtags":"#considering_share_buyback, #growth_strategy, #health_managementDX","jir_key_figures":"Backlog revenue: Unknown\nAdvertising revenue: Unknown\nDX revenue: Unknown","jir_meta_title":"\u3010MRSO\u30112Q Highlights\uff5cExpansion of Revenue Backlog and Growth Strategy","jir_meta_description":"Summary of MRSO's 2Q results and growth strategy. Traces of revenue and backlog, progress in the DX domain, outlook and capital policy directions. Key metrics of investor interest explained.","jir_og_title":"MRSO 2Q Highlights\uff5cGrowth Strategy","jir_og_description":"Overview of MRSO's 2Q results and growth strategy. Summary of revenue and backlog growth, expansion in the DX area, and future plans.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":60743,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-104015","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n